Degenerative Brain Disorder

Also known as: Cerebral degeneration / Cerebral degeneration (disorder) / Cerebral degeneration, unspecified / Degenerative brain disorder (disorder)

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB04599	Aniracetam	A nootropic drug used to ameliorate memory and attention disturbances accompanying cerebrovascular diseases and degenerative brain disorders.
DB04660	Choline alfoscerate	A natural choline that is used to manage declining cognitive function associated with neurodegenerative and vascular diseases.
DB12153	Citicoline	An endogenous intermediate in the formation of phosphatidylcholine from choline which is thought to have neuroprotective effects.

Drug	Drug Name	Target	Type
DB04599	Aniracetam	5-hydroxytryptamine receptor 2A	target
DB04599	Aniracetam	Dopamine D2 receptor	target
DB04599	Aniracetam	Glutamate receptor 2	target
DB04599	Aniracetam	Glutamate receptor 3	target
DB04660	Choline alfoscerate	Ganglioside GM2 activator	target
DB12153	Citicoline	LicC protein	target

Drug	Drug Name	Phase	Status	Count